Results 121 to 130 of about 49,657 (223)

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

, 2020
Marianna Nalli, Jorge I. Armijos Rivera, Domiziana Masci, Antonio Coluccia, Roger Badía, Eva Riveira‐Muñoz, A. Brambilla, Elisabetta Cinquina, Ombretta Turriziani, Francesca Falasca, Myriam Catalano, Cristina Limatola, José A. Esté, Giovanni Maga, Romano Silvestri, Emmanuele Crespan, Giuseppe La Regina   +16 more
openalex   +1 more source

HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan

Infection and Drug Resistance, 2018
Hung-Chin Tsai,1–3 I-Tzu Chen,1 Susan Shin-Jung Lee,1,2 Yao-Shen Chen1,2 1Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 2Faculty of Medicine, School of Medicine, National Yang-Ming ...
Tsai HC, Chen IT, Lee SS, Chen YS
doaj  

Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice. [PDF]

Open Forum Infect Dis, 2021
Borghetti A, Giacomelli A, Borghi V, Ciccullo A, Dusina A, Fabbiani M, Rusconi S, Zazzi M, Mussini C, Di Giambenedetto S.   +9 more
europepmc   +1 more source

Brief communication: characteristics of primary drug resistance in newly diagnosed HIV-infected individuals in Ganzhou, China

AIDS Research and Therapy
Background Primary drug resistance (PDR) is an important cause of antiretroviral therapy (ART) failure. However, the prevalence and characteristics of PDR in Ganzhou remain unclear.
Dan-Dan Huang, Jun-Jie Liu, Ya-Ting Chen, Rong-Rong Yang, Jun-Zhi Su, Qian Gao, Xin Chen   +6 more
doaj   +1 more source

Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2. [PDF]

Drug Metab Dispos, 2020
Miller SR, Hau RK, Jilek JL, Morales MN, Wright SH, Cherrington NJ.   +5 more
europepmc   +1 more source

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

, 2016
Lawrence Mbuagbaw, Sara Mursleen, James Irlam, Alicen B. Spaulding, George W. Rutherford, Nandi Siegfried   +5 more
openalex   +1 more source

Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

, 2015
Zheng-Yong Wan, Jin Yao, Yuan Tao, Tian-Qi Mao, Xin-Long Wang, Yi-Pei Lu, Haifeng Wang, Hong Yin, Yan Wu, Fen‐Er Chen, Erik De Clercq, Dirk Daelemans, Christophe Pannecouque   +12 more
openalex   +2 more sources

In Vivo, Nucleoside Reverse‐Transcriptase Inhibitors Alter Expression of Both Mitochondrial and Lipid Metabolism Genes in the Absence of Depletion of Mitochondrial DNA [PDF]

, 2005
Patrick Mallon, Patrick Unemori, Rebecca Sedwell, Adrienne Morey, Martina Rafferty, Kenneth Williams, Donald J. Chisholm, Katherine Samaras, Sean Emery, Anthony D. Kelleher, David A. Cooper, Andrew Carr, SAMA Investigators   +12 more
openalex   +1 more source

Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondrial DNA and RNA in Human Skeletal Muscle Cells

, 2008
Akihiko Saitoh, Richard Haas, Robert K. Naviaux, Neurita G. Salva, Justine K. Wong, Stephen A. Spector   +5 more
openalex   +1 more source

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial* [PDF]

, 2010
Ann‐Brit Eg Hansen, Niels Obel, Henrik Nielsen, C Pedersen, J Gerstoft   +4 more
openalex   +1 more source